PubHawk
November 2021 PMID 34292508

Investigational Treatments for Epidermolysis Bullosa.

Ping-Chen Hou, Han-Tang Wang, Stasha Abhee, Wei-Ting Tu, John A McGrath, Chao-Kai Hsu

Download social card

Mentions

6
Peak: 2 in Jul 2021
across 3 sources since Jul 2021

Extended reach

3,359
potential audience

Total likes

34

Video views

2,282

Mentions per month

Jul 2021 – Jun 2024

Where it's discussed

  • X / Twitter2 posts
  • YouTube2 videos
  • Facebook2 posts

AI synopsis

What people are saying

The discussions highlight the development of innovative approaches such as gene editing, cell therapies, and drug repurposing, reflecting a positive but measured tone. Phrases like 'covering gene, cell-based, protein' therapies signal recognition of scientific advances, while the overall moderate scores imply curiosity and acknowledgment rather than passionate advocacy or skepticism.

AgreementModerate agreement

Most discussions recognize the importance of exploring advanced treatments for EB, indicating general support or acknowledgment of the article's relevance.

InterestModerate interest

Participants show moderate curiosity about the detailed approaches like gene and cell therapies, but overall enthusiasm is cautious.

EngagementModerate engagement

Comments include brief summaries and references to different therapy types, suggesting moderate engagement without deep critique or personal stories.

ImpactModerate impact

The discussions suggest awareness of the potential impact these new treatments may have on patient outcomes, though without strong calls to action or advocacy.

Abstract in brief

  • EB is a group of rare blistering skin disorders caused by genetic differences, with four main types distinguished by specific features and skin layer involvement.
  • Current treatments mainly support symptom management like wound care and pain relief, but recent research is exploring therapies that target the underlying genetic issues, including gene editing, cell therapies, and drug repurposing.
  • Advances in translational research, such as gene and cell-based therapies, offer promising new approaches to improve the quality of life and clinical outcomes for people living with EB.]
Read the full abstract

Top posts

Most liked on X and Bluesky
ラクバイオ
@raqbio · X

Investigational Treatments for Epidermolysis Bullosa | SpringerLink https://t.co/hE3q2g4khA

Jul 23, 2021 · 2 likes · 1,001 followers View post →
Kathy Fraser
@AmJClinDerma · X

This review of Investigational Treatments for #Epidermolysis Bullosa covers gene, cell-based, protein and miscellaneous small molecule or repositioned drug therapies to help combat this debilitating disorder. https://t.co/gaxF43f0fm https://t.co/bEoc9MXJwM

Jul 22, 2021 · 77 followers View post →

All mentions

ラクバイオ
@raqbio · X

Investigational Treatments for Epidermolysis Bullosa | SpringerLink https://t.co/hE3q2g4khA

Jul 23, 2021 · 2 likes · 1,001 followers View post →
Kathy Fraser
@AmJClinDerma · X

This review of Investigational Treatments for #Epidermolysis Bullosa covers gene, cell-based, protein and miscellaneous small molecule or repositioned drug therapies to help combat this debilitating disorder. https://t.co/gaxF43f0fm https://t.co/bEoc9MXJwM

Jul 22, 2021 · 77 followers View post →